Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11093498 | PMC |
| http://dx.doi.org/10.1097/JS9.0000000000001209 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
The application of organoids in treatment decision-making for digestive system cancers: progress and challenges.
Mol Cancer
August 2025
Cancer Science Institute of Singapore, National University of Singapore, Singapore, 117599, Singapore.
Digestive system cancers-including gastric, liver, colorectal, esophageal, and pancreatic malignancies-remain leading causes of cancer death, with treatment resistance posing major challenges in advanced disease. Patient-derived cancer organoids (PDCOs), 3D mini-tumors grown from patient biopsies, have revolutionized personalized oncology by faithfully replicating tumor biology and enabling predictive drug testing for chemotherapy, radiotherapy, targeted therapy, and immunotherapy. While demonstrating good predictive accuracy, current limitations include incomplete tumor microenvironments, variable establishment rates, and lengthy processing times.
View Article and Find Full Text PDFFrom Bench to Bedside: Emerging Paradigms in CAR-T Cell Therapy for Solid Malignancies.
Adv Sci (Weinh)
August 2025
Department of Medical Oncology, Chongqing University Cancer Hospital, Chongqing, 400030, China.
Immunotherapy, particularly chimeric antigen receptor T cell (CAR-T) therapy, has revolutionized the treatment of hematological malignancies and autoimmune diseases. However, its efficacy in solid tumors remains limited due to challenges such as tumor heterogeneity, an immunosuppressive microenvironment, and poor T cell infiltration. This review first summarizes the primary causes and challenges that restrict CAR-T therapy in the treatment of solid tumors, followed by an overview of recent advancements in gastric cancer, liver cancer, and glioma, where early trials have demonstrated promising clinical potential.
View Article and Find Full Text PDFThe mA-SFRP2-NFAT/TOX axis governs T cell exhaustion in gastric cancer.
Cell Oncol (Dordr)
August 2025
Department of Laboratory Medicine, Shanghai Tongji Hospital, School of Medicine, Tongji University, Shanghai, 200065, China.
Background: While immune checkpoint inhibitors (ICIs) have revolutionized cancer therapy, their efficacy in gastric cancer (GC) remains limited, underscoring the need for mechanistic biomarkers of immune evasion.
Methods: We analyzed mA RNA modification patterns in the TCGA-STAD cohort, stratifying patients into three subtypes. Functional assays (including CRISPR-based SFRP2 modulation, NFAT/TOX reporter systems, and ex vivo T-cell exhaustion models) were employed to dissect the m1A-SFRP2-NFAT/TOX axis.
Harnessing the chimeric antigen receptor engineered cells in gastrointestinal cancer immunotherapy.
Int Immunopharmacol
August 2025
Digestive Disease Research Center, Ardabil University of Medical Sciences, Ardabil, Iran. Electronic address:
Gastrointestinal (GI) cancers pose a significant global health concern. Their prevalence is continually increasing, and managing them remains a significant clinical hurdle. Adoptive cell therapies designed to express chimeric antigen receptors (CARs) or transgenic T cell receptors (TCRs) to identify and destroy cancer cells have emerged as a promising strategy for achieving long-term remissions in cancer patients.
View Article and Find Full Text PDFAutonomic nervous system development-related signature as a novel predictive biomarker for immunotherapy in pan-cancers.
Front Immunol
August 2025
Department of Oncology, Affiliated Hospital of Nanjing University of Chinese Medicine, Jiangsu Province Hospital of Chinese Medicine, Nanjing, Jiangsu, China.
Background: Immunotherapy has revolutionized cancer treatment. However, its clinical application remains limited. There is an urgent need for new predictive and prognostic biomarkers that can identify more patients with objective and durable responses and thus, improve the accuracy of prognosis.
View Article and Find Full Text PDF